Follow
Vincent Lemaire
Vincent Lemaire
Principal Scientist, Clinical Pharmacology, Systems Modeling Lead, Genentech
Verified email at gene.com
Title
Cited by
Cited by
Year
Modeling the interactions between osteoblast and osteoclast activities in bone remodeling
V Lemaire, FL Tobin, LD Greller, CR Cho, LJ Suva
Journal of theoretical biology 229 (3), 293-309, 2004
5512004
Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy
A Rotte, JY Jin, V Lemaire
Annals of Oncology 29 (1), 71-83, 2018
3362018
Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process
V Lemaire, J Belair, P Hildgen
International journal of pharmaceutics 258 (1-2), 95-107, 2003
1582003
Numerical bifurcation analysis of delay differential equations arising from physiological modeling
K Engelborghs, V Lemaire, J Belair, D Roose
Journal of mathematical biology 42, 361-385, 2001
1142001
Sequential recruitment and combinatorial assembling of multiprotein complexes in transcriptional activation
V Lemaire, CF Lee, J Lei, R Métivier, L Glass
Physical review letters 96 (19), 198102, 2006
372006
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations
V Lemaire, CS Shemesh, A Rotte
Journal of Experimental & Clinical Cancer Research 40 (1), 311, 2021
332021
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies
V Lemaire, DR Cox
Bulletin of Mathematical Biology, 1–48, 2018
102018
Spatial effects in modeling pharmacokinetics of rapid action drugs
P Lafrance, V Lemaire, F Varin, F Donati, J Bélair, F Nekka
Bulletin of mathematical biology 64 (3), 483-500, 2002
102002
From cold to hot: changing perceptions and future opportunities for quantitative systems pharmacology modeling in cancer immunotherapy
V Lemaire, D Bassen, M Reed, R Song, S Khalili, YT Lien, L Huang, ...
Clinical Pharmacology & Therapeutics 113 (5), 963-972, 2023
82023
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
A Bichara, S Gervais, D Le Garrec, P Ouadji, V Sant, S Gosein, V Lemaire, ...
US Patent App. 12/252,117, 2008
7*2008
Modeling and simulation to optimize efficacy and tolerability for once a day trazodone formulation
V Lemaire, C Benquet, D LeGarrec, SD Robertson Sy, SM Stahl
Abstract presented at: The European College of Neuropsychopharmacology meeting, 2009
3*2009
Sample Size Determination and Statistical Hypothesis Testing for Core Centration in Press Coated Tablets
PL de Micheaux, V Lemaire
Open Journal of Statistics 2 (3), 269-273, 2012
12012
No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost
V Lemaire, C Hu, PH van der Graaf, S Chang, W Wang
Clinical Pharmacology & Therapeutics, 2023
2023
IDENTIFYING BIOLOGICAL SIGNALS DIFFERENTIATING RESPONDERS AND NON-RESPONDERS TO MPDL3280A (ANTI-PDL1) IN NON-SMALL CELL LUNG CANCER USING QUANTITATIVE SYSTEMS PHARMACOLOGY …
V Lemaire, A Rotte, K Gadkar, JY Jin, S Ramanujan
CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S119-S119, 2019
2019
Modélisation de la libération de substances bioactives et des conséquences sur la dynamique physiologique
V Lemaire
University of Montreal, 2003
2003
The system can't perform the operation now. Try again later.
Articles 1–15